Chronic granulomatous disease: towards gene therapy.
Article
Thrasher, A., Segal, A. and Casimir, C. 1993. Chronic granulomatous disease: towards gene therapy. Immunodeficiency. 4 (1-4), pp. 327-33.
Type | Article |
---|---|
Title | Chronic granulomatous disease: towards gene therapy. |
Authors | Thrasher, A., Segal, A. and Casimir, C. |
Abstract | Failure of a superoxide generating system, the NADPH oxidase, present in neutrophils and other phagocytes gives rise to chronic granulomatous disease (CGD), a group of single gene inherited disorders all characterised by an extreme susceptibility to pyogenic infection, with potentially fatal consequences. About 30% of CGD cases are due to an autosomally inherited deficiency of a 47 kDa cytoplasmic component of the oxidase (p47-phox). Epstein-Barr virus (EBV) immortalised B-lymphocyte lines established from these CGD patients also express this NADPH oxidase defect and consequently are rendered incapable of generating superoxide on stimulation. We have utilised a p47-phox-deficient EBV-transformed B cell line as a recipient for retroviral transfer of a functional p47-phox cDNA. The presence and activity of the retrovirally encoded p47-phox in the transduced cells is demonstrated and we show that this restores their capacity to generate superoxide. |
Research Group | Molecular Biology group |
Publisher | Harwood Academic Publishers |
Journal | Immunodeficiency |
ISSN | 1067-795X |
Publication dates | |
1993 | |
Publication process dates | |
Deposited | 02 Dec 2009 |
Output status | Published |
Language | English |
https://repository.mdx.ac.uk/item/81z4w
40
total views0
total downloads4
views this month0
downloads this month